Montelukast Prescribing at BALSALL COMMON & MERIDEN GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
803
Total Quantity
25.5K
NHS Cost
£1.2K
vs National Avg
+17.3%
BALSALL COMMON & MERIDEN GROUP PRACTICE prescribed 803 items of Montelukast over the last 12 months at a cost of £1,235 to the NHS. This is 17.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
81
Jul 2026
76
Jul 2026
67
Jul 2026
66
Jul 2026
59
Jul 2026
74
Jul 2026
62
Jul 2026
67
Jul 2026
57
Jul 2026
65
Jul 2026
64
Jul 2026
65
Prescribing Details
| Total Items | 803 |
|---|---|
| Total Quantity | 25,517 |
| Total NHS Cost | £1,235 |
| Presentations | 4 different forms |
| vs National Average | +17.3% |
Montelukast Prescribing Comparison
| This practice | 803 items |
|---|---|
| National average per practice | 685 items |
| Difference | +17.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.